c22 Sphingomyelin (d18:1/22:0)
CAS: 94359-12-3
Ref. 3D-UDA35912
1mg | Nachfragen | |
5mg | Nachfragen | |
10mg | Nachfragen |
Produktinformation
C22 Sphingomyelin (d18:1/22:0) is a type of sphingolipid that has been studied for its potential in cancer treatment. It has been shown to have anticancer properties by inducing apoptosis or programmed cell death in cancer cells. In addition, it can inhibit the activity of certain kinases, which are enzymes that play a role in tumor growth and progression. This sphingomyelin analog has been tested on human and Chinese hamster ovary cells and has demonstrated efficacy against various types of tumors, including breast and colon cancer. Furthermore, it has been found to be an inhibitor of hyaluronan-mediated motility receptor, which is involved in cancer cell migration and invasion. C22 Sphingomyelin (d18:1/22:0) is a promising candidate for the development of kinase inhibitors for the treatment of cancer.
Chemische Eigenschaften
Technische Anfrage zu: 3D-UDA35912 c22 Sphingomyelin (d18:1/22:0)
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.